Venetoclax and obinutuzumab in chronic lymphocytic leukemia

被引：98

作者：

Fischer, Kirsten ^{[1
]}

Al-Sawaf, Othman ^{[1
]}

Fink, Anna-Maria ^{[1
]}

Dixon, Mark ^{[2
]}

Bahlo, Jasmin ^{[1
]}

Warburton, Simon ^{[2
]}

Kipps, Thomas J. ^{[3
]}

Weinkove, Robert ^{[4
,5
,6
]}

Robinson, Sue ^{[7
]}

Seiler, Till ^{[8
]}

Opat, Stephen ^{[9
]}

Owen, Carolyn ^{[10
]}

Lopez, Javier ^{[11
]}

Humphrey, Kathryn ^{[2
]}

Humerickhouse, Rod ^{[12
]}

Tausch, Eugen ^{[13
]}

Frenzel, Lukas ^{[1
]}

Eichhorst, Barbara ^{[1
]}

Wendtner, Clemens-M. ^{[1
,14
]}

Stilgenbauer, Stephan ^{[13
]}

Langerak, Anton W. ^{[15
]}

van Dongen, Jacque J. M. ^{[15
]}

Boettcher, Sebastian ^{[16
]}

Ritgen, Matthias ^{[16
]}

Goede, Valentin ^{[1
]}

Mobasher, Mehrdad ^{[17
]}

Hallek, Michael ^{[1
]}

机构：

[1] Univ Hosp Cologne, Dept Internal Med 1, Ctr Integrated Oncol Cologne Bonn, Kerpener Str 62, D-50937 Cologne, Germany

[2] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England

[3] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA

[4] Wellington Blood & Canc Ctr, Capital & Coast Dist Hlth Board, Wellington, New Zealand

[5] Malaghan Inst Med Res, Wellington, New Zealand

[6] Univ Otago Wellington, Dept Pathol & Mol Med, Wellington, New Zealand

[7] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[8] Univ Hosp Ludwig Maximilians Univ Munich, Dept Internal Med 3, Munich, Germany

[9] Monash Univ, Monash Hematol, Clayton, Vic, Australia

[10] Tom Baker Canc Clin, Dept Hematol, Calgary, AB, Canada

[11] Hosp Ramon & Cajal, Madrid, Spain

[12] AbbVie Inc, N Chicago, IL USA

[13] Univ Ulm, Dept Internal Med 3, Ulm, Germany

[14] Klinikum Schwabing, Dept Hematol Oncol Immunol Palliat Care Infect Di, Munich, Germany

[15] Erasmus MC, Dept Immunol, Lab Med Immunol, Rotterdam, Netherlands

[16] Univ Hosp Schleswig Holstein, Dept Med 2, Campus Kiel, Kiel, Germany

[17] Genentech Inc, San Francisco, CA USA

来源：

BLOOD | 2017年 / 129卷 / 19期

关键词：

PHASE-2;

D O I：

10.1182/blood-2017-01-761973

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2702 / 2705

页数：4

共 11 条

[1] Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial [J].

Boettcher, Sebastian ;

Ritgen, Matthias ;

Fischer, Kirsten ;

Stilgenbauer, Stephan ;

Busch, Raymonde M. ;

Fingerle-Rowson, Guenter ;

Fink, Anna Maria ;

Buehler, Andreas ;

Zenz, Thorsten ;

Wenger, Michael Karl ;

Mendila, Myriam ;

Wendtner, Clemens-Martin ;

Eichhorst, Barbara F. ;

Doehner, Hartmut ;

Hallek, Michael J. ;

Kneba, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) :980-988

[2] Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia [J].

Byrd, John C. ;

Flynn, Joseph M. ;

Kipps, Thomas J. ;

Boxer, Michael ;

Kolibaba, Kathryn S. ;

Carlile, David J. ;

Fingerle-Rowson, Guenter ;

Tyson, Nicola ;

Hirata, Jamie ;

Sharman, Jeff P. .

BLOOD, 2016, 127 (01) :79-86

[3]

Flinn I, 2014, BLOOD, V124, P4687

[4] Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions [J].

Goede, Valentin ;

Fischer, Kirsten ;

Busch, Raymonde ;

Engelke, Anja ;

Eichhorst, Barbara ;

Wendtner, Clemens M. ;

Chagorova, Tatiana ;

de la Serna, Javier ;

Dilhuydy, Marie-Sarah ;

Illmer, Thomas ;

Opat, Stephen ;

Owen, Carolyn J. ;

Samoylova, Olga ;

Kreuzer, Karl-Anton ;

Stilgenbauer, Stephan ;

Doehner, Hartmut ;

Langerak, Anton W. ;

Ritgen, Matthias ;

Kneba, Michael ;

Asikanius, Elina ;

Humphrey, Kathryn ;

Wenger, Michael ;

Hallek, Michael .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (12) :1101-1110

[5] Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group [J].

Kovacs, Gabor ;

Robrecht, Sandra ;

Fink, Anna Maria ;

Bahlo, Jasmin ;

Cramer, Paula ;

von Tresckow, Julia ;

Maurer, Christian ;

Langerbeins, Petra ;

Fingerle-Rowson, Gunter ;

Ritgen, Matthias ;

Kneba, Michael ;

Doehner, Hartmut ;

Stilgenbauer, Stephan ;

Klapper, Wolfram ;

Wendtner, Clemens-Martin ;

Fischer, Kirsten ;

Hallek, Michael ;

Eichhorst, Barbara ;

Boettcher, Sebastian .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) :3758-+

[6]

Ritgen M, 2016, 21 C EUR HEM ASS 9 1

[7] Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia [J].

Roberts, Andrew W. ;

Davids, Matthew S. ;

Pagel, John M. ;

Kahl, Brad S. ;

Puvvada, Soham D. ;

Gerecitano, John F. ;

Kipps, Thomas J. ;

Anderson, Mary Ann ;

Brown, Jennifer R. ;

Gressick, Lori ;

Wong, Shekman ;

Dunbar, Martin ;

Zhu, Ming ;

Desai, Monali B. ;

Cerri, Elisa ;

Enschede, Sari Heitner ;

Humerickhouse, Rod A. ;

Wierda, William G. ;

Seymour, John F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04) :311-322

[8] Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study [J].

Seymour, John F. ;

Ma, Shuo ;

Brander, Danielle M. ;

Choi, Michael Y. ;

Barrientos, Jacqueline ;

Davids, Matthew S. ;

Anderson, Mary Ann ;

Beaven, Anne W. ;

Rosen, Steven T. ;

Tam, Constantine S. ;

Prine, Betty ;

Agarwal, Suresh K. ;

Munasinghe, Wijith ;

Zhu, Ming ;

Lash, L. Leanne ;

Desai, Monali ;

Cerri, Elisa ;

Verdugo, Maria ;

Kim, Su Young ;

Humerickhouse, Rod A. ;

Gordon, Gary B. ;

Kipps, Thomas J. ;

Roberts, Andrew W. .

LANCET ONCOLOGY, 2017, 18 (02) :230-240

[9] Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia [J].

Smolej, Lukas .

CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (23) :3399-3405

[10] ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets [J].

Souers, Andrew J. ;

Leverson, Joel D. ;

Boghaert, Erwin R. ;

Ackler, Scott L. ;

Catron, Nathaniel D. ;

Chen, Jun ;

Dayton, Brian D. ;

Ding, Hong ;

Enschede, Sari H. ;

Fairbrother, Wayne J. ;

Huang, David C. S. ;

Hymowitz, Sarah G. ;

Jin, Sha ;

Khaw, Seong Lin ;

Kovar, Peter J. ;

Lam, Lloyd T. ;

Lee, Jackie ;

Maecker, Heather L. ;

Marsh, Kennan C. ;

Mason, Kylie D. ;

Mitten, Michael J. ;

Nimmer, Paul M. ;

Oleksijew, Anatol ;

Park, Chang H. ;

Park, Cheol-Min ;

Phillips, Darren C. ;

Roberts, Andrew W. ;

Sampath, Deepak ;

Seymour, John F. ;

Smith, Morey L. ;

Sullivan, Gerard M. ;

Tahir, Stephen K. ;

Tse, Chris ;

Wendt, Michael D. ;

Xiao, Yu ;

Xue, John C. ;

Zhang, Haichao ;

Humerickhouse, Rod A. ;

Rosenberg, Saul H. ;

Elmore, Steven W. .

NATURE MEDICINE, 2013, 19 (02) :202-208

← 1 2 →